/Companies

Neusignal Therapeutics株式会社

Tokyo, JP · Founded 2022 · 6 known investors

Find your way into Neusignal Therapeutics株式会社

Sign up to see every warm intro you have to Neusignal Therapeutics株式会社

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neusignal Therapeutics株式会社 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.

Founders & leadership

Neusignal Therapeutics株式会社 was founded in 2022 by 有本 達 and 森口 茂樹.

有達
有本 達代表取締役社長CEO
森茂
森口 茂樹創業科学者/特別顧問

Investors · 6

Frequently asked questions

What does Neusignal Therapeutics株式会社 do?
Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.
Who founded Neusignal Therapeutics株式会社?
Neusignal Therapeutics株式会社 was founded by 有本 達, 森口 茂樹 in 2022.
Who are Neusignal Therapeutics株式会社's investors?
Neusignal Therapeutics株式会社's investors include Angel Bridge Co.,Ltd., Red Capital, Fast Track Initiative, Keio Innovation Initiative, Nippon Venture Capital, The Gogin Capital.
Where is Neusignal Therapeutics株式会社 headquartered?
Neusignal Therapeutics株式会社 is headquartered in Tokyo, JP.